· Periodic Report
Q3 operating profit KRW 11.9 billion, up 22.0% from a year earlier
Samjin Pharmaceutical sold KRW 84.1 billion in Q3 and made KRW 11.9 billion from its main business, up 22.0% from a year earlier and up 66.8% from the previous quarter.